Dr. Emily Hoffman Smith, MD

Dr. Smith practices at SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri.

Dr. Smith's NPI, 1528324670, was assigned on April 3, 2012. Dr. Smith holds Michigan license 4301101125.

Dr. Smith's primary practice is SLUCare Physician Group Dermatology Pathology, at 1225 S Grand Blvd, 3rd Floor, Saint Louis, MO 63104. The practice phone is (314) 617-2709.

Dr. Smith's primary practice is SLUCare Physician Group Dermatology Pathology in Saint Louis, Missouri. Dr. Smith is also affiliated with SSM Health Saint Louis University Hospital. The medical group on file is SLUCare Physician Group. Dmand AI also links Dr. Smith to 1 more hospital, 1 clinical lab, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Smith's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Smith practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatopathology is Dr. Smith's primary specialty in the NPI Registry, under taxonomy code 207ND0900X. Dmand AI has Dr. Smith's licenses on file in 2 states: Michigan and Missouri.

CMS data shows 4,104 Medicare services from Dr. Smith across 17 procedure codes in 2024, for 1,923 Medicare patients. Medicare paid $204,837 for them.

CMS counts 1,923 Medicare patients who saw Dr. Smith in 2024. The largest group is 65 to 74, with 865 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Smith's median patient age at 71, with 54% women.

In 2024, Dr. Smith wrote 649 Medicare Part D claims for 136 patients. 81% of them were for generic drugs. CMS names the drug for 452 of them, across 14 drugs with 11 or more claims each, at $236,068 in total drug cost. In 2023, CMS named 20 claims across 1 drug.

Dr. Smith accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 167 procedures of removal of skin lesions by Dr. Smith, more than 78% of the clinicians it reports for that procedure.

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 4 general payments to Dr. Smith from 4 drug and device companies from 2021 to 2025. Consulting fees make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $2,248.